Analysis

  • September’s top news stories

    Novartis signed an agreement to sell parts of its Sandoz US business to Aurobindo Pharma USA for $900m, and the California Department of Insurance filed a lawsuit against AbbVie for...

  • Gene and cell therapies: making manufacturing work

    Gene and cell therapies are potentially revolutionary, but complex science and manufacturing issues could hold them back in the market. We speak to Dr Pascale Bouillé of France-based Flash Therapeutics,...

  • CHMP recommends 13 new drugs for European approval

    The EMA’s CHMP has recommended 13 medicines, including three orphan drugs, for marketing approval by the European Commission, as well as confirming its earlier negative guidance on Sarepta’s Exondys. The...